Expert Opinion on Therapeutic Targets

Targeting platelets for prevention and treatment of cardiovascular disease
pp. 1523-1533(11)
Authors: Duhamel, Todd A; Xu, Yan-Jun; Arneja, Amarjit S; Dhalla, Naranjan S

Targeting insulin-like growth factor-1 to treat Alzheimer's disease
pp. 1535-1542(8)
Author: Torres-Aleman, Ignacio

The parkin protein as a therapeutic target in Parkinson's disease
pp. 1543-1552(10)
Author: Winklhofer, Konstanze F

Molecular prognostic factors in patients with pancreatic cancer
pp. 1553-1569(17)
Authors: Tonini, Giuseppe; Pantano, Francesco; Vincenzi, Bruno; Gabbrielli, Armando; Coppola, Roberto; Santini, Daniele

Targeting apoptosis in solid tumors: the role of bortezomib from preclinical to clinical evidence
pp. 1571-1586(16)
Authors: Russo, Antonio; Fratto, Maria E; Bazan, Viviana; Schiró, Valentina; Agnese, Valentina; Cicero, Giuseppe; Vincenzi, Bruno; Tonini, Giuseppe; Santini, Daniele

Selective Raf inhibition in cancer therapy
pp. 1587-1609(23)
Authors: Khazak, Vladimir; Astsaturov, Igor; Serebriiskii, Ilya G; Golemis, Erica A

Targeting Akt to increase the sensitivity of neuroblastoma to chemotherapy: lessons learned from the brain-derived neurotrophic factor/TrkB signal transduction pathway
pp. 1611-1621(11)
Authors: Li, Zhijie; Thiele, Carol J

Molecular mechanisms of cellular senescence and immortalization of human cells
pp. 1623-1637(15)
Author: Kiyono, Tohru

The role of estrogen receptor in melanoma
pp. 1639-1648(10)
Authors: Tanemura, Atsushi; van Hoesel, Anneke Q; Mori, Takuji; Yu, Terrance; Hoon, Dave SB

Is DARPP-32 a potential therapeutic target?
pp. 1649-1661(13)
Authors: Reis, Helton J; Rosa, Daniela VF; Guimarães, Melissa M; Souza, Bruno R; Barros, Alexandre GA; Pimenta, Flávio J; Souza, Renan P; Torres, Karen CL; Romano-Silva, Marco A